Recently, our company's leadership visited the Shenzhen Advanced Institute of Technology of the Chinese Academy of Sciences (hereinafter referred to as "Advanced Institute") and held talks with the representatives of Advanced Institute in Shenzhen to conduct an in-depth discussion on the cooperation in the field of boron drugs.
Boron drugs, a compound with special chemical properties, have broad application prospects in the field of boron neutron capture therapy.
During the talk, our company's leadership and the representatives of Advanced Institute conducted an in-depth exchange on the research and application of boron drugs. Both sides agreed that through cooperation, we can give full play to each other's advantages, accelerate the research process of boron drugs and promote their clinical application.
Our company's leadership stated that this cooperation will help accelerate the research process of boron drugs, provide more effective treatment methods for patients. At the same time, this cooperation will also promote the long-term strategic cooperation between our company and Advanced Institute, driving mutual development.
The representatives of Advanced Institute also stated that this cooperation is a concrete practice of mutual advantage and resource sharing, which will help promote technological innovation and development in the field of boron drugs. Advanced Institute will give full play to its scientific research advantages to fully support the implementation of cooperation projects and make contributions to the successful completion of this cooperation.